title: Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm.
authors.forename: Lila
authors.initials: L
authors.lastname: Gilis
authors.forename: Laure
authors.initials: L
authors.lastname: Lebras
authors.forename: Fadhela
authors.initials: F
authors.lastname: Bouafia-Sauvy
authors.forename: Daniel
authors.initials: D
authors.lastname: Espinouse
authors.forename: Pascale
authors.initials: P
authors.lastname: Felman
authors.forename: Francoise
authors.initials: F
authors.lastname: Berger
authors.forename: Gilles
authors.initials: G
authors.lastname: Salles
authors.forename: Bertrand
authors.initials: B
authors.lastname: Coiffier
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Michallet
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001215:Asparaginase / Q000008:administration & dosage*; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism*; D019002:CD56 Antigen / Q000276:immunology*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology; D033581:Stem Cell Transplantation / Q000379:methods*; D014184:Transplantation, Homologous / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D019002:CD56 Antigen; D001215:Asparaginase; D008727:Methotrexate